Related Experiment Video
Updated: Jun 1, 2026
09:58
Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
Acute myeloid leukemia: a central role for the ETS factor ERG
1Radboud University, Department of Molecular Biology, Faculty of Science, Nijmegen Centre for Molecular Life Sciences, 6500 HB, Nijmegen, The Netherlands. j.martens@ncmls.ru.nl
The International Journal of Biochemistry & Cell Biology
|June 14, 2011
Summary
Acute myeloid leukemia involves abnormal E-twenty-six (ETS) transcription factors. This study discusses the role of the ERG ETS factor in normal and cancerous blood development and potential therapeutic targeting.
Area of Science:
- Hematology
- Molecular Biology
- Oncology
Background:
- Acute myeloid leukemia (AML) is a myeloid cancer characterized by immature progenitor cell proliferation.
- Aberrant regulation of E-twenty-six (ETS) transcription factors, like PU.1 (SPI1), is implicated in AML pathogenesis.
- ETS factors are crucial for normal blood development, with defects linked to hematopoietic issues.
Purpose of the Study:
- To discuss the role of the ETS factor ERG in normal hematopoiesis.
- To explore the involvement of ERG in aberrant blood development and AML.
- To review potential therapeutic strategies targeting ERG in leukemia.
Main Methods:
- Literature review and synthesis of existing research on ETS factors in hematopoiesis and leukemia.
- Analysis of the function of ERG in normal and malignant blood cell development.
- Identification and discussion of therapeutic targets related to ERG.
Main Results:
- ERG is identified as a key player in normal hematopoiesis.
- Dysregulation of ERG contributes to aberrant blood development.
- ERG presents a potential therapeutic target for AML and related disorders.
Conclusions:
- ERG plays a significant role in both normal and aberrant blood development.
- Targeting ERG offers promising therapeutic avenues for hematological malignancies.
- Further research into ERG's function can advance AML treatment strategies.
Related Concept Videos
02:23Master Transcription Regulators
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
01:28Role of Hematopoietic Growth Factors
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:07MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...